Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Pediatric rheumatic disease

Vaccination in pediatric rheumatic disease—risks and benefits

Nature Reviews Rheumatology volume 8, pages 188–190 (2012)Cite this article

Subjects

In an age in which immunosuppression is the standard of care for many pediatric rheumatic diseases, balancing the risks and benefits of vaccinations is forefront. Three main issues—addressed in new guidelines—surround vaccination practices in these patients: safety, immunogenicity and effects of the vaccine on the underlying rheumatic disease.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Tynjala, P. et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann. Rheum. Dis. 70, 1605–1612 (2011).

    Article  CAS  Google Scholar 

  2. Ilowite, N. T. et al. Impaired in vivo and in vitro antibody responses to bacteriophage phi X 174 in juvenile rheumatoid arthritis. J. Rheumatol. 14, 957–963 (1987).

    CAS  PubMed  Google Scholar 

  3. Heijstek, M. W. et al. EULAR recommendations for vaccination in paediatric patients with rheumatic diseases. Ann. Rheum. Dis. 70, 1704–1712 (2011).

    Article  CAS  Google Scholar 

  4. Aikawa, N. E. et al. Corticosteroid: major factor for reduced immunogenicity of 2009 influenza A (H1N1) vaccine in patients with juvenile autoimmune rheumatic disease. J. Rheumatol. 39, 167–173 (2012).

    Article  CAS  Google Scholar 

  5. Dell'era, L. et al. Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. Vaccine 30, 936–940 (2012).

    Article  CAS  Google Scholar 

  6. Long, C. B. et al. Humoral and cell-mediated immune responses to monovalent 2009 influenza A/H1N1 and seasonal trivalent influenza vaccines in high-risk children. J. Pediatr. 160, 74–81 (2012).

    Article  CAS  Google Scholar 

  7. Rehnberg, M. et al. Vaccination response to protein and carbohydrate antigens in patients with rheumatoid arthritis after rituximab treatment. Arthritis Res. Ther. 12, R111 (2010).

    Article  Google Scholar 

  8. Perricone, C., Agmon-Levin, N., Valesini, G. & Shoenfeld, Y. Vaccination in patients with chronic or autoimmune rheumatic diseases: the ego, the id and the superego. Joint Bone Spine 79, 1–3 (2012).

    Article  Google Scholar 

  9. Shoenfeld, Y. & Agmon-Levin, N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J. Autoimmun. 36, 4–8 (2011).

    Article  CAS  Google Scholar 

  10. Balofsky, A., Agmon-Levin, N. & Shoenfeld, Y. The new H1N1 and HPV vaccines and old fears. Curr. Opin. Rheumatol. 22, 431–436 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Pediatric Rheumatology, The Children's Hospital at Montefiore, 3415 Bainbridge Avenue, Rosenthal 3rd Floor, Bronx, 10467, NY, USA

    Ginger Janow & Norman T. Ilowite

Authors
  1. Ginger Janow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Norman T. Ilowite
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Norman T. Ilowite.

Ethics declarations

Competing interests

N. T. Ilowite has acted as a consultant for Genentech and Novartis, and has received grant or research support from Regeneron. G. Janow declares no competing interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Janow, G., Ilowite, N. Vaccination in pediatric rheumatic disease—risks and benefits. Nat Rev Rheumatol 8, 188–190 (2012). https://doi.org/10.1038/nrrheum.2012.13

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2012.13

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research